Syapse Appoints David Pomerantz as Chief Commercial Officer

NEXT STORY
Onxeo Receives Notice of Allowance from USPTO for New Patent Strengthening Protection of AsiDNA™ via Systemic Administration in the United States
PREV STORY
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Marburg Virus Showing 100% Protection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update

Net cash used in operating and investing activities was $25.4 million in the first ...

author_avatar
NASDAQ Market News

ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer

PLAN-LES-OUATES, Switzerland, Sept. 22, 2015 (GLOBE NEWSWIRE) -- ObsEva, a Swiss biopharmaceutical company developing ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Eight Idylla(TM) Performance Studies to be Presented at the Association for Molecular Pathology Conference in the US

PRESS RELEASE: 1 November 2018, 07:00 CEST/00:00 CDT Eight Idylla(TM) Performance Studies to be Presented ...

author_avatar
NASDAQ Market News